Immatics Appoints Venkat Ramanan as CFO
Ticker: IMTX · Form: 6-K · Filed: Oct 1, 2025 · CIK: 1809196
Sentiment: neutral
Topics: management-change, cfo-appointment
Related Tickers: IMTX
TL;DR
Immatics names Venkat Ramanan as new CFO, effective Oct 1, 2025.
AI Summary
Immatics N.V. announced on October 1, 2025, the appointment of Venkat Ramanan as its new Chief Financial Officer, effective immediately. Ramanan brings over 25 years of financial leadership experience in the biopharmaceutical sector to Immatics.
Why It Matters
The appointment of a new CFO is a significant leadership change that can impact financial strategy and investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a personnel change and does not contain significant financial or operational risks.
Key Players & Entities
- Immatics N.V. (company) — Company making the announcement
- Venkat Ramanan (person) — Newly appointed Chief Financial Officer
- October 1, 2025 (date) — Effective date of appointment
FAQ
Who has been appointed as the new Chief Financial Officer of Immatics N.V.?
Venkat Ramanan has been appointed as the new Chief Financial Officer of Immatics N.V.
When is Venkat Ramanan's appointment as CFO effective?
Venkat Ramanan's appointment as CFO is effective October 1, 2025.
What is Venkat Ramanan's relevant experience?
Venkat Ramanan has over 25 years of experience in finance, strategy, and operations across biopharmaceutical companies.
What is the filing type?
This is a Form 6-K report.
What is the principal executive office address for Immatics N.V.?
The principal executive office is located at Paul-Ehrlich-Straße 15, 72076 Tübingen, Federal Republic of Germany.
Filing Stats: 414 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2025-10-01 07:15:04
Filing Documents
- dp235216_6k.htm (6-K) — 12KB
- dp235216_ex9901.htm (EX-99.1) — 17KB
- image_001.jpg (GRAPHIC) — 4KB
- image_002.jpg (GRAPHIC) — 4KB
- 0000950103-25-012612.txt ( ) — 41KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMATICS N.V. Date: October 1, 2025 By: /s/ Harpreet Singh Name: Harpreet Singh Title: Chief Executive Officer